Purpose: To compare the effect of a single drop of different lubricant eye gels on tear film thickness (TFT) as measured with ultrahigh-resolution optical coherence tomography (UHR-OCT) in patients with mild-to-moderate dry eye disease (DED). Methods: The study followed a randomized, single-masked, observer-blinded parallel group design. Patients received a single dose of either unpreserved trehalose 3% + hyaluronic acid 0.15% (TH), hyaluronic acid 0.2% (HA) or polyethylene glycol 0.4% + propylene glycol 0.3% (PP) eye drops. In total, 60 patients were included and TFT was measured using a custom-built UHR-OCT system. Results: The mean TFT at baseline was 3.5 AE 0.7 lm. There was a significant difference in the time-course of TFT between the three groups (p = 0.001 between groups). Ten minutes after instillation, TFT increased by 155.8 AE 86.6%, 65.7 AE 71.5% and 33.4 AE 19.6% in the PP, TH and HA group, respectively (p < 0.001 between groups). Thirty minutes after instillation, the effect of all three different agents on TFT was comparable. Sixty and 120 min after administration, a significant increase in TFT was only seen for the TH group, but not for the other products (60 min: p < 0.021 between groups; 120 min: p < 0.037 between groups). Conclusion: In conclusion, we observed differences in TFT after administration of the lubricant gels. Ten minutes after instillation, a pronounced increase in TFT was observed in all groups. As compared to the other products, the combination of trehalose 3% + hyaluronic acid 0.15% offers a significantly longer increase in TFT indicating for a longer residence time.
Introduction
Dry eye disease (DED) is a highly prevalent disorder of the tears and the ocular surface (DEWS 2007a) . Key players in the pathophysiology of DED include instability and hyperosmolarity of the tear film as well as inflammation of the ocular surface and the lacrimal glands (Sullivan et al. 2010; Mantelli et al. 2013; Messmer 2015) . Clinically, dry eye is divided into those with decreased tear production and those with increased tear evaporation, but both mechanisms are frequently present in individual patients (DEWS 2007) .
The treatment of DED is dependent on the severity of the disease (DEWS 2007) . Strategies for the therapy include tear supplementation with lubricants, tear retention, tear stimulation, topical or systemic anti-inflammatory therapy and environmental approaches. In all stages of the disease, tear supplementation with lubricants remains a mainstay of the treatment. The array of tear supplements used is wide. Products differ in terms of preservatives, electrolyte composition, viscosity and lipid content, and some may also offer osmoprotective effects (Messmer 2007; Foulks 2008; Baudouin et al. 2013) .
A common problem with lubricants is the need for frequent instillation of the products (DEWS 2007; Johnson et al. 2008) . This is related to the relatively short residence time of lubricants on the ocular surface (Snibson et al. 1992; Wilson 2004; Urtti 2006; Gupta et al. 2015) . Theoretical considerations and experimental data indicate that an increased viscosity may increase ocular residence time (Paugh et al. 2008; Zhu & Chauhan 2008; Bandlitz et al. 2014 ). As such, several lubricant eye gels are on the market potentially offering longer therapeutic efficacy and reduced instillation frequency. The disadvantage of gel-based formulations lies in their side-effects such as blurred vision or sticky feeling (Bron et al. 1998; Ridder et al. 2005; Hiraoka et al. 2010) .
In this study, we compared the changes in precorneal tear film thickness (TFT) after administration of three commercially available gel-based lubricants indicated for DED. For quantification of TFT, we used a custom-built ultrahigh-resolution optical coherence tomography (OCT) system, which has previously been used to characterize effects of topical lubricants (Kaya et al. 2015; Schmidl et al. 2015a ). Measurement of TFT was performed to get insight into the residence time of the lubricants on the ocular surface after single-drop administration.
Materials and Methods

Subjects
The study was performed in accordance with the Declaration of Helsinki and the Good Clinical Practice (GCP) guidelines of the European Union. The study protocol was approved by the Ethics Committee of the Medical University of Vienna. Sixty-one male and female patients with DED were included according to the inclusion/ exclusion criteria outlined below. All subjects gave written informed consent after detailed personal explanation.
Participating subjects underwent a prestudy screening, which was carried out within the two weeks before the first study day. All patients were asked to stop instillation of topical lubricants 12-24 hr before the screening examination, which included medical history, pregnancy test in women with childbearing potential, subjective assessment of symptoms of dry eye syndrome using the Ocular Surface Disease Index (OSDI) questionnaire, an ophthalmic examination including visual acuity using the ETDRS acuity charts, slit-lamp biomicroscopy and indirect funduscopy, measurement of break-up time (BUT), Schirmer I test and measurement of intraocular pressure (IOP).
Patients were included based on the following criteria: OSDI ≥22, BUT ≤10 seconds or Schirmer I test between 2 and 5 mm. DED was categorized as moderate to severe based on the symptoms as assessed with OSDI (Miller et al. 2010) . Further inclusion criteria were age of at least 18 years, normal ophthalmic findings except DED, ametropia <6 dioptres and history of DED for at least three months. The eye with the lower BUT was chosen as study eye. If BUT was identical for both eyes, the eye with the lower Schirmer I test was chosen. If Schirmer I test results were also identical for both eyes, the right eye was used for study purposes.
The following exclusion criteria were defined for this study: Treatment with any ophthalmic drug except topical lubricants. To avoid any influence on TFT measurement, patients taking systemic NSAIDS, immunosuppressants, corticosteroids or any medication which could affect lachrymal function (e.g. antidepressants, anxiolytics, neuroleptics, antihistamines, cholinergics, antimuscarines, phenothiazine and beta-blocker) were not included in the study. Further exclusion criteria were ocular surgery in the month preceding the study, known hypersensitivity to one of the administered products, pregnancy, planned pregnancy or lactating, participation in a clinical trial in the four weeks preceding the study, symptoms of a clinically relevant illness in the 2 weeks before the first study day, presence or history of a severe medical condition as judged by the clinical investigator and wearing of contact lenses. 
Study design
This study was performed in a randomized, single-masked, observer-blinded parallel group design. Patients were randomly assigned to TH-HA, HA or PG-PRG eye drops. To avoid any influence on the TFT measurements, a washout period of at least 12 hr was scheduled and all patients were asked to stop administration of topical lubricants in the 12-24 hr before the study day.
The study day started with a baseline measurement of TFT. Thereafter, one of the three products was instilled in both eyes. Administration of the eye gels was performed by an investigator who was not involved in data collection or data analysis. Three minutes after administration, patient's feeling upon instillation was assessed. Measurements of TFT were repeated 10, 30, 60, 120, 240 and 360 min after instillation. During the breaks between the measurements, patients remained in the hospital to guarantee comparable environmental conditions. After the last measurement, the following procedures were performed: assessment of patient's satisfaction (subjective evaluation of ocular comfort), visual acuity, BUT, Schirmer I test. Finally, an assessment of adverse events was performed at the end of the study day.
Methods
Measurement of TFT using OCT
The ultrahigh-resolution custom-built OCT system that was employed in this study was presented previously (Werkmeister et al. 2013; Aranha Dos Santos et al. 2015) . A titanium:sapphire laser (Integral OCT; Femtolasers Produktions GmbH, Vienna, Austria) with a power of 600 lW at a central wavelength of 800 nm and a broadband half maximum (FWHM) bandwidth of 170 nm is used as light source. The calculated axial resolution of the OCT system is 1.2 lm in tissue. The optical components and the spectrometer are optimized for the broad bandwidth allowing for analysis of the full-wavelength spectrum. The transverse resolution of the OCT system is approximately 21 lm at the front side of the cornea. The power of the probe beam impinging onto the cornea was set to 600 lm, which is well below the maximum permissible exposure as specified by ANSI and IEC 60825-1. As a patient module, a modified slitlamp headrest is employed to minimize head movements and facilitate alignment relative to the subject's eye. During the alignment procedure, the subjects were asked to blink regularly. Before the measurements were started, patients were asked to blink once, and immediately after opening of the eyes, the recording began. Three 3-dimensional volumes with a size of 4 mm 9 4 mm 9 1 mm (horizontal 9 vertical 9 depth) were acquired within 3-seconds, each containing 512 9 256 9 1024 pixels. For analysis, the first volume was discarded and only the second and third volumes were used. This approach has previously been shown to provide optimal reproducibility (R.M. Werkmeister, V. Aranha Dos Santos & L. Schmetterer, unpublished data). For calculation of central TFT, the 15 horizontal frames above the central specular reflex of the probe beam at the apex of the cornea were analysed in each volume.
Break-up time
Tear break-up time was measured following the guidelines described in the Report of the International Dry Eye WorkShop (DEWS 2007) . Five microlitres of Minims fluorescein sodium 2.0% eye drops was applied in the conjunctival sac of the eye, and patients were instructed to blink naturally to distribute the fluorescein. Patients were asked to stare straight ahead without blinking, until told otherwise. By means of a stopwatch, the time between last complete blink and first appearance of a dry spot was recorded. The slit-lamp magnification was set at 10X, the background illumination intensity was kept constant (cobalt blue light), and a yellow filter was used to enhance observation of the tear film over the entire cornea.
Schirmer I test
Schirmer I test without anaesthesia was performed following the guidelines published in the Report of the International Dry Eye WorkShop (DEWS 2007) . Schirmer paper strips were inserted in the eye over the lower lid margin, midway between the middle and outer third. The patient was asked to close the eye, and after 5 min, the wetting of the Schirmer paper was measured.
Intraocular pressure
Intraocular pressure (IOP) was measured with a slit-lamp-mounted Goldmann applanation tonometer. Before each measurement, one drop of oxybuprocainhydrochloride combined with sodium fluorescein was used for local anaesthesia.
Ocular Surface Disease Index (OSDI)
Symptoms of dry eye were assessed using the OSDI. The questionnaire underlying the OSDI is specifically designed for patients with dry eye syndrome and asks patients about the frequency of specific symptoms and their impact on visionrelated functioning.
Patient's satisfaction
After the last measurement, patients were asked about the satisfaction with the eye drops according to a four-point subjective scale (strongly agree, agree, disagree and strongly disagree). The questions used to assess satisfaction are listed in detail in Table 2 .
Data analysis
Statistical analysis was performed as 'per protocol'. To detect differences in TFT between treatments, a three-way repeated-measures ANOVA model was applied. Planned comparisons within the ANOVA model were performed to assess differences in TFT between timepoints and groups. All values are presented as means AE SD. A p-level of 0.05 or less was considered significant. For the data arising from the questionnaires, a Kruskal-Wallis ANOVA was used. All statistical analyses were carried out using CSS STATISTICA (Version 6.0; StatSoft, Tulsa, OK, USA).
Results
A total of 61 patients aged between 19 and 76 with DED were included, of which 60 completed the study according to the protocol (age: 45.6 AE 13.4 years, 23 male, 37 female). One patient was excluded because consent was withdrawn on the study day.
The mean duration of DED in the study population was 7.6 AE 5.9 years, and the mean TFT at baseline on the study day was 3.53 AE 0.73 lm in the study eye. Table 1 lists baseline outcome parameters in the three study groups separately. No significant differences were observed between the three study groups. Administration of lubricants significantly increased TFT in all three groups (p < 0.001). The time-course of TFT was significantly different between the three groups (p = 0.003). All eye drops lead to a significant increase in TFT 10 min after administration. The increase was more pronounced for PG-PRG than for TH-HA and HA (p < 0.001). In the PG-PRG group, values as high as 9.52 AE 4.07 were reached 10 min after drop administration (Figs 1 and 2) . Planned comparison analysis within the ANOVA model showed no difference in terms of TFT between the 30-min values comparing the three study groups (p = 0.26). Sixty and 120 min after administration, a significant increase in TFT was only seen with TH-HA, but not with the other products (60 min: p = 0.021 between groups; 120 min: p = 0.037 between groups). Overall BUT increased 360 min after instillation of the gel lubricants (p < 0.001). No difference in the change in BUT was, however, observed between the three groups (ANOVA between groups: p = 0.07). None of the treatments significantly changed Schirmer I test results (ANOVA overall effect p = 0.052, effect between groups p = 0.83). Neither IOP nor ETDRS visual acuity changed after administration of the eye gels (data not shown).
At the end of the study day, patients were asked about satisfaction with the received eye drops. No difference was seen between the three groups ( Table 2) .
Discussion
In the present study, we investigated the effect of different lubricant gels on TFT as measured with a custom-built ultrahigh-resolution OCT system. With all administered products, we saw a pronounced increase in TFT 10 min after instillation, which was not seen with lubricant eye drops in previous studies (Kaya et al. 2015; Schmidl et al. 2015) . In addition, we observed that HA and PG-PRG increase TFT for approximately 30 min, whereas with TH-HA, a significant effect on TFT was seen for as long as 120 min. The latter is in good agreement with our previous results using TH-HA eye drops (Schmidl et al. 2015) .
Literature data on ocular residence time of topical lubricants on the ocular surface is sparse. So far, most previous studies used radioactive labelling in combination with quantitative gamma scintigraphy or small animal positron emission tomography to follow the residence of polymers in the eye (Wilson 2004; Kuntner et al. 2011; Gupta et al. 2015) . In these previous experiments, longer residence times were detected with higher viscosity products than with low molecular HA (Snibson et al. 1990; Wilson 2004 ). There are, however, important differences between the technique we applied and gamma scintigraphy. Whereas the OCT technology offers the advantage of true non-invasiveness, gamma scintigraphy allows for investigation into polymer in different tissues such as the cornea, the inner canthus and the lacrimal duct. In addition, gamma scintigraphy is capable of measuring topical redistribution of the drug on the ocular surface indicating that the lower half of the eye is seeing higher concentrations of hydrophilic drugs (Wilson 2004) .
Interestingly, the duration of the increase in TFT induced by gels in the present study was comparable with that observed with eye drop formulations used in our previous studies (Kaya et al. 2015; Schmidl et al. 2015) . As mentioned above, gamma scintigraphy experiments indicate that higher viscosity products have longer residence times, but this was particularly true for lacrimal ducts (Wilson 2004) . On the other hand, Paugh et al. (2008) reported that the ocular residence time is to a large degree determined by factors other than viscosity (Paugh et al. 2008 ). Based on their results, they speculated that spreading characteristics, pseudoplasticity and mucoadhesion are key factors in Fig. 1 . Absolute values of tear film thickness (TFT) over time (mean AE SD, n = 60) after instillation of lubricant eye gels (HA: hyaluronic acid 0.2%, PG-PRG: polyethylene glycol 0.4%, propylene glycol 0.3%, TH-HA: trehalose 3%, hyaluronic acid 0.15%). Data up to 120 min after instillation are shown. *Significant versus baseline. determining ocular retention. So far, a study directly comparing products with different viscosity on TFT using OCT is lacking.
Although the three products under study share physical properties such as high viscosity, considerable differences between the three gel products need to be taken into consideration when interpreting our results. TH-HA and HA both comprise hyaluronic acid as a viscoelastic component to assure topical lubrication. It is known that because of its viscoelastic properties, hyaluronic acid may stay longer on the ocular surface than other lubricants (Snibson et al. 1990 ). Indeed, data from animal experiments show that hyaluronic acid has a longer ocular residency time compared to other lubricant agents such as carboxymethylcellulose or hydroxypropyl methylcellulose (Zheng et al. 2014) . In addition, the latter experiment also indicates that the ocular retention time of topical hyaluronic acid is dependent on its concentration and most probably on the chain length of the polymers (Zheng et al. 2014) . Given that TH-HA and HA used in the current study differ slightly in terms of hyaluronic acid concentration, we cannot fully exclude that differences in hyaluronic acid concentration and/or composition might influence TFT.
Besides hyaluronic acid, TH-HA also comprises carbomer 0.25% and trehalose 3%. Although the relative contribution of the ingredients on ocular residency time is not clear, we have shown in a previous study that a combination of trehalose and hyaluronic acid shows a longer residency time compared to HA or sodium chloride (Schmidl et al. 2015) . This is compatible with the data of the current study, again showing increased residence time of TH-HA compared to the other lubricant gels. The reason for this increased residency time of the TH-HA combination is not entirely clear, but may be related to the interaction of TH with lipid membranes involving the surrounding hydration shell (Huxtable 1992) .
The mechanisms of TH in protecting corneal epithelial cells have been reported in some details (Izawa et al. 2006; Luyckx & Baudouin 2011; Hovakimyan et al. 2012; Hill-Bator et al. 2014 ) and include water replacement in the desiccated cells by hydrogen bonding interactions with polar groups on membrane lipids and proteins (Leidy et al. 2004) , modification of the tetrahedral hydrogen-bond structure of water and rearrangement of the remaining water molecules around biological structures (Teramoto et al. 2008) and reduced tendency to form crystals that can damage cell organelles (Luyckx & Baudouin 2011) . These bioprotective effects of TH have also been proven in a number of clinical studies (Matsuo 2004; Ramoth et al. 2013; Pinto-Bonilla et al. 2015) . Nowadays, both eye drop and gel formulations are available containing TH and HA. Such combination products offer the advantage of bioprotective effects of TH with the well-documented lubrication effects of HA.
The third lubricant gel used in the current study comprises two demulcents (polyethylene glycol and propylene glycol) in combination with the mucomimetic agent hydroxypropyl guar. Clinical evidence indicates that treatment with PG-PRG reduces ocular surface staining and increases patients' satisfaction in patients with dry eye (Guillon et al. 2010; Labetoulle et al. 2016) . Once instilled on the ocular surface, the cross-linked hydroxypropyl guar creates a dense polymeric meshwork on the ocular surface that stabilizes the ocular tear film. Further, the hydroxypropyl guar network is intended to prolong the retention of the two other components polyethylene glycol and propylene glycol and thus the lubricating effect on the ocular surface (Benelli 2011) . This may partially explain our data showing that PG-PRG leads to a more pronounced increase in TFT than the other two tested formulation. This effect, however, is limited to 10 min after instillation.
There is no direct evidence that the duration of TFT increase after administration of lubricants as measured with OCT is directly related to the duration of the treatment effect. The International Workshop on Meibomian Gland Dysfunction, however, comes to the conclusion that the duration of action of topical lubricants is dependent on the residence time on the ocular surface as well as on patients' characteristics (Geerling et al. 2011) . This is supported by data indicating that HA offers longer lasting relief of dry eye symptoms than saline (Johnson et al. 2006 ) and a previous cross-sectional study showing that reduced TFT is associated with the symptoms of DED (Schmidl et al. 2015) .
A variety of different approaches were realized to assess the tear film via OCT. Many of these approaches used assessment of tear meniscus (Wang Table 2 . Assessment of patients' satisfaction with the administered treatment at the end of the study day. The range of the four-point subjective scale was strongly agree, agree, disagree and strongly disagree. In the table, data for strongly agree and agree as well as for disagree and strongly disagree are pooled. Points on the grading scale that did not occur in any group are not shown. Palakuru et al. 2007 Palakuru et al. , 2008 Ibrahim et al. 2010; Koh et al. 2010; Chen et al. 2011; Park et al. 2012; Qiu et al. 2012; Altan-Yaycioglu et al. 2013; Fukuda et al. 2013; Bartuzel et al. 2014; Canan et al. 2014; Sizmaz et al. 2014; Akiyama et al. 2015; Tukenmez-Dikmen et al. 2015) . For measuring precorneal tear film, the resolution of commercially available OCT systems is not sufficient for quantitative measurement. As such, OCT systems with ultra-broadband light sources were realized that offer sufficient resolution for quantification of TFT (Wang et al. 2006; Yadav et al. 2011; Kottaiyan et al. 2012; Schmoll et al. 2012 ) and algorithms to quantify thickness were proposed (Huang et al. 2013 (Huang et al. , 2014 Aranha Dos Santos et al. 2015) . The custom-built OCT system used in the present study based on Ti: sapphire technology appears to be suitable for measuring TFT in patients with DED, but also to study the effect of different treatment regimen on TFT. Different approaches were realized to characterize treatment effects in patients with DED using OCT-based technology. Cyclosporin, for instance, has been shown to increase tear meniscus ). Napoli and co-workers observed that topical instillation of sodium carboxymethylcellulose is associated with a two-layered structure in the OCT image (Napoli et al. 2014b ). On top of the epithelial surface of the cornea, an outer band with high reflectivity and an inner band with low reflectivity are observed (Napoli et al. 2014) . The same group showed that artificial tears can be used as adhesion markers for studying adhesion properties of the cornea in patients with meibomian gland dysfunction (Napoli et al. 2014) and that morphometric changes in the precorneal tear film and the lower tear meniscus can be quantified using OCT (Napoli et al. 2014 ).
In the current study, TFT values between 3 and 10 lm were measured depending on the severity of the disease, the treatment as well as the time-point of measurement. Currently, no normative values for TFT exist, but our studies in healthy volunteers indicate that baseline levels of approximately 5 lm can be considered normal (Werkmeister et al. 2013 ). Larger, cross-sectional studies are necessary to further clarify this issue. Additionally, 10 min after administration, we observed very high TFT values particularly after administration of PG-PRG. Previous reports indicate blurred vision after administration of high viscous eye drops, most probably caused by increased high-order aberrations and increased forward light scatter (Koh et al. 2013 ). The present study was, however, not designed to clarify whether high TFT values caused by topical lubricants may impact vision and potentially quality of life after instillation. To address the relation between visual function distortion and tear film thickness after instillation of lubricants is a subject that warrants further investigation.
All administered eye drops were well tolerated in this study, and no differences in patient's satisfaction were detected between treatments. Whereas BUT increased over time, no differences were observed between the three lubricant gels. The present study was, however, not designed to detect such differences, and longer treatment periods as well as larger sample size would be required to study potential differences of the products in terms of signs and symptoms of DED.
In conclusion, significant differences in TFT after administration of the three lubricant gels were observed in the present study. Ten minutes after instillation, a pronounced increase in TFT was observed in all groups, which was most pronounced with PG-PRG. As compared to the other products, HA-TH offers a longer lasting increase in TFT reflecting a longer residence time on the cornea.
